Company intelligence / Profile preview

Symatese Aesthetics

Chaponost, Auvergne-Rhône-Alpes, Francesymatese-aesthetics.com ↗

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Symatese Aesthetics is a commercial-stage company specializing in premium medical devices for aesthetic medicine and reconstructive surgery. Its flagship product NEVELIA®, a bi-layer silicone-collagen dermal regeneration matrix developed jointly with its parent company Symatese, is marketed globally for the treatment of severe skin loss such as third-degree burns and chronic wounds. The company also develops breast implants and plans to launch new HA dermal fillers.

Therapeutic areas: DermatologyWomen's Health
Modalities: DeviceBiologicPolymer-based device
Industry: Therapeutic Medical Devices

Partnerships

Parent company partnerships include L’Oréal/Episkin for tissue engineering/cosmetics testing modelsOther group-level partners include Galderma, Evolus

Beyond the preview

Go deeper on Symatese Aesthetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symatese Aesthetics.

Explore the full profile